99 related articles for article (PubMed ID: 2141819)
1. [Model of choreic movement in monkey--contribution for understanding the mechanism of chorea in Huntington's disease].
Kanazawa I
Jikken Dobutsu; 1990 Apr; 39(2):168-72. PubMed ID: 2141819
[No Abstract] [Full Text] [Related]
2. [Choreic movements and dopamine--implications to the underlying neural mechanisms involved].
Kanazawa I
Rinsho Shinkeigaku; 1989 Dec; 29(12):1519-21. PubMed ID: 2517049
[TBL] [Abstract][Full Text] [Related]
3. Roles of dopamine and its receptors in generation of choreic movements.
Kanazawa I; Murata M; Kimura M
Adv Neurol; 1993; 60():107-12. PubMed ID: 8093572
[TBL] [Abstract][Full Text] [Related]
4. [Activity of dopaminergic neurons of the substantia nigra following lesions of the neostriatum by kainic acid].
Doudet D; Gross C; Bioulac B
C R Seances Soc Biol Fil; 1984; 178(3):298-306. PubMed ID: 6238656
[TBL] [Abstract][Full Text] [Related]
5. The relationships of aging changes in the basal ganglia to manifestations of Huntington's chorea.
Finch CE
Ann Neurol; 1980 May; 7(5):406-11. PubMed ID: 6446874
[No Abstract] [Full Text] [Related]
6. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
[TBL] [Abstract][Full Text] [Related]
7. Kainic acid animal model predicts therapeutic agents in Huntington's chorea.
Borison RL; Diamond BI
Trans Am Neurol Assoc; 1979; 104():67-9. PubMed ID: 162258
[No Abstract] [Full Text] [Related]
8. Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease.
Coyle JT; Ferkany JW; Zaczek R
Neurobehav Toxicol Teratol; 1983; 5(6):617-24. PubMed ID: 6142425
[TBL] [Abstract][Full Text] [Related]
9. Animal models of Huntington's disease.
Gárdián G
Ideggyogy Sz; 2006 Nov; 59(11-12):396-9. PubMed ID: 17203874
[TBL] [Abstract][Full Text] [Related]
10. Huntington's disease: modeling the gait disorder and proposing novel treatments.
Banaie M; Sarbaz Y; Gharibzadeh S; Towhidkhah F
J Theor Biol; 2008 Sep; 254(2):361-7. PubMed ID: 18621402
[TBL] [Abstract][Full Text] [Related]
11. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
12. Fly models of Huntington's disease.
Marsh JL; Pallos J; Thompson LM
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R187-93. PubMed ID: 12925571
[TBL] [Abstract][Full Text] [Related]
13. [Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
Carolei A; Del Castillo G
Clin Ter; 1979 Sep; 90(6):591-621. PubMed ID: 43793
[No Abstract] [Full Text] [Related]
14. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
15. On chorea: possible neuronal mechanisms.
Kanazawa I
Clin Neurol Neurosurg; 1992; 94 Suppl():S100-2. PubMed ID: 1320477
[TBL] [Abstract][Full Text] [Related]
16. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
Fenney A; Jog MS; Duval C
Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471
[TBL] [Abstract][Full Text] [Related]
17. [The Cools and van Rossum theory and the pharmacology of Huntington's chorea].
Donatelli L
Clin Ter; 1977 Jun; 81(5):395-416. PubMed ID: 18317
[No Abstract] [Full Text] [Related]
18. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
Kenney C; Hunter C; Davidson A; Jankovic J
Mov Disord; 2007 Jan; 22(1):10-3. PubMed ID: 17078062
[TBL] [Abstract][Full Text] [Related]
19. Improvement of choreic movements by 1 Hz repetitive transcranial magnetic stimulation in Huntington's disease patients.
Brusa L; Versace V; Koch G; Bernardi G; Iani C; Stanzione P; Centonze D
Ann Neurol; 2005 Oct; 58(4):655-6. PubMed ID: 16178020
[No Abstract] [Full Text] [Related]
20. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.
Antal A; Bodis-Wollner I
Neurobiology (Bp); 1993; 1(2):101-22. PubMed ID: 8111350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
